BLISSGVS — Bliss GVS Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹11.58bn
- IN₹11.42bn
- IN₹7.70bn
- 90
- 55
- 48
- 75
Annual cashflow statement for Bliss GVS Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,423 | 1,041 | 1,278 | 1,061 | 1,461 |
| Depreciation | |||||
| Non-Cash Items | 8.8 | 291 | -490 | 392 | 118 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,091 | -864 | 394 | -1,297 | -318 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 468 | 640 | 1,355 | 343 | 1,524 |
| Capital Expenditures | -593 | -91.2 | -740 | -938 | -283 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 114 | -379 | -190 | 860 | -1,045 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -479 | -470 | -930 | -77.5 | -1,328 |
| Financing Cash Flow Items | -48.8 | -63.2 | -29.6 | -63 | -60.6 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -63 | -208 | -237 | -249 | -209 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.03 | -22.1 | 88.5 | 30.2 | -14.2 |